Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer [Phase 3]
Phase 3 trial update comparing platinum-based therapy with dostarlimab (TSR-042) and niraparib versus standard platinum-based therapy as fir…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Disitamab Vedotin Combined With Platinum and Bevacizumab as First-Line and Maintenance Therapy for HER2-Expressing, HRD-Negative High-Risk Ovarian Cancer: A Multicenter, Non-Randomized, Single-Arm Phase II Clinical Study [Phase 2]
This clinical trial update describes a Phase II, multicenter, non-randomized, single-arm study evaluating disitamab vedotin in combination w…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian [Phase 1]
A Phase 1 study investigating AZD2014 (an mTORC1/2 inhibitor) or AZD5363 (an AKT inhibitor) in recurrent endometrial and ovarian cancers, wi…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer [NA]
This ClinicalTrials.gov entry describes a Rutgers-led study focused on enhancing coping and communication for women diagnosed with gynecolog…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Study of Nutritional Supplement Shakes in People About to Receive Their Debulking Surgery for Ovarian Cancer
This clinical trial update covers a study of nutritional supplement shakes given to people about to undergo debulking surgery for ovarian ca…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors [Phase 1, Phase 2]
ACE-86225106 is being studied in Phase 1/2 for advanced solid tumors with ongoing recruitment; the study includes BRCA1/BRCA2 mutation-assoc…
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors [Phase 1]
Phase 1 trial evaluating LVGN3616 and LVGN6051±LVGN7409 with nab-paclitaxel or bevacizumab and cyclophosphamide in various metastatic solid …
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers [Phase 1]
Phase 1b study evaluating SL-172154 in combination with other agents in platinum-resistant ovarian, fallopian tube, and primary peritoneal c…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903 [Phase 1]
Phase 1 study of RP903 conducted by Risen (Suzhou) Pharma Tech Co., Ltd. has completed, evaluating safety, tolerability, pharmacokinetics, e…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas [Phase 2]
A Phase 2 clinical trial update describes a program for in-home cancer treatment with remote expert support, currently recruiting for patien…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Autophagy Maintenance (AUTOMAIN) [Phase 2]
Phase 2 clinical trial update for Autophagy Maintenance (AUTOMAIN) in ovarian cancer; currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Skeletal Muscle Energy Metabolism in Women With Weight Loss and Ovarian and/or Endometrial Cancer With Weight Loss [NA]
ClinicalTrials.gov update for NCT03027479, a study on skeletal muscle energy metabolism in women with weight loss and ovarian and/or endomet…
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: EWOC-1 Trial: Carboplatin +/- Paclitaxel in Vulnerable Elderly Patients With Stage III-IV Advanced Ovarian Cancer [Phase 2]
The EWOC-1 Phase 2 trial evaluating carboplatin with or without paclitaxel in vulnerable elderly patients with stage III-IV advanced ovarian…
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Tolerance of Intraperitoneal (IP) Nivolumab After Extensive Debulking Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Ovarian Carcinoma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the safety and tolerability of intraperitoneal nivolumab after extensive debulking surgery and HIPEC in …
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer [Phase 1]
Phase 1 trial evaluating adding ipatasertib to paclitaxel and carboplatin for Stage III/IV ovarian, fallopian tube, and primary peritoneal c…
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Spectroscopy in Ovarian Cancer
The University of Exeter conducted a completed clinical trial evaluating spectroscopy techniques in ovarian cancer.
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Phase II Study of Weekly Paclitaxel/Nab-Paclitaxel, Pembrolizumab, and Mirabegron for Recurrent Ovarian Cancer [Phase 2]
Phase II trial evaluating weekly paclitaxel/nab-paclitaxel with pembrolizumab and mirabegron for recurrent ovarian cancer is currently recru…
-
CLINICAL_TRIALS other · 2025-12-19Clinical Trial Update: Predicting Outcome of Cytoreduction in Advanced Ovarian Cancer [NA]
This clinical trial entry indicates a recruiting study to predict the outcome of cytoreduction in advanced ovarian cancer (Stage III/Stage I…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Validation of the Sentinel Lymph Node Technique in Early-stage Ovarian Cancer (SENTOV II) [Phase 3]
This Phase 3 clinical trial update notes SENTOV II evaluating the sentinel lymph node technique in early-stage ovarian cancer, which is curr…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: RESCUE Study (REcurrent Ovarian Cancer Secondary Cytoreduction Using Chemotherapy rEsponse) [Phase 2]
This is a Phase 2 clinical trial update for the RESCUE study evaluating secondary cytoreduction using chemotherapy response in recurrent, pl…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer (N-Dur) [Phase 1, Phase 2]
This Phase 1/2 study tests durvalumab in combination with chemotherapy as frontline treatment for ovarian cancer and related gynecologic can…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer [Phase 1]
A Phase 1 clinical trial to evaluate the safety and efficacy of OPB-101 in platinum-resistant ovarian cancer is ongoing. The study is curren…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: A Study of Carboplatin and Paclitaxel Chemotherapy With Nivolumab With or Without Ipilimumab in Patients With Ovarian Cancer [Phase 1]
Phase 1 study evaluating carboplatin and paclitaxel chemotherapy with nivolumab, with or without ipilimumab, in ovarian cancer including hig…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study [EARLY_Phase 1]
A completed early-phase feasibility trial evaluating indocyanine green–enabled mapping of ovarian sentinel lymph nodes in ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: A Study of Avutometinib + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer in Japanese Patients [Phase 2]
Phase 2 clinical trial evaluating Avutometinib plus Defactinib in Japanese patients with recurrent low-grade serous ovarian cancer; the stud…